Targeted neutralizing IgY antibodies against SGLT1 glucose transporter reduce glucose uptake and improve glycemic profile in vivo https://www.biorxiv.org/content/10.1101/2023.05.06.539723v1?med=mas
Targeted neutralizing IgY antibodies against SGLT1 glucose transporter reduce glucose uptake and improve glycemic profile in vivo https://www.biorxiv.org/content/10.1101/2023.05.06.539723v1?med=mas